# Cajal Neuroscience

**Canonical:** https://apis.io/providers/cajal-neuroscience/  
**Website:** https://www.cajal-tx.com/  
**APIs profiled:** 0

Cajal Neuroscience, which now operates publicly as Cajal Therapeutics, is a Seattle, Washington biotechnology company founded in 2020 by Alex Vaughan, Andrew Dervan and Ian Peikon, and launched in November 2022 with a $96 million Series A led by The Column Group and Lux Capital with participation from Two Sigma Ventures and Bristol Myers Squibb. The company develops small-molecule and RNA medicines that restore iron homeostasis, built around "iron mobilizers" — small molecules that transport iron across membranes into the compartments where it is required, bypassing disease-driven bottlenecks such as chronic inflammation, altered iron transporter expression and lysosomal dysfunction. Its pipeline spans systemic disease (CTX001, a clinical-stage iron mobilizer for anemia of chronic kidney disease; CTX201 and CTX211, preclinical siRNA programs for inflammatory anemia and myelofibrosis anemia) and CNS disease (a discovery-stage brain-penetrant iron mobilizer for Parkinson's disease). This is a therapeutics company, not a software or data platform company: it publishes no developer program, no public API, and no machine-readable API contract. Its public GitHub organization contains open-source laboratory hardware and firmware (a drone-motor spin coater, a microfluidic pressure sensor, a flow sensor) plus forks of third-party single-cell and genomics analysis tooling — none of which expose a network API.

## Kin Score — 9.1 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 9.1).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 5.3 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Cajal Neuroscience Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Drug Discovery, Neurodegeneration, Neuroscience, Therapeutics, Life Sciences, Genomics, Health

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/cajal-neuroscience/). Scores are computed from the provider's own public artifacts under a published rubric.